Clinical Study on the Efficacy and Continuous Docetaxel Based Chemotherapy Treatment for Castration-Resistant Prostate Cancer
We report a retrospective study on the efficacy, adverse events and the factors for continuous docetaxel (DOC) therapy for patients with castration-resistant prostate cancer (CRPC). Between April 2007 and April 2015, 37 CRPC patients were treated with DOC therapy at Kanazawa Medical University Hospi...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 9 vom: 09. Sept., Seite 351-357
|
1. Verfasser: |
Chikazawa, Ippei
(VerfasserIn) |
Weitere Verfasser: |
Inoue, Shinya,
Nakazawa, Yusuke,
Nakai, Dan,
Morita, Nobuyo,
Tanaka, Tatsuro,
Motoo, Yoshiharu,
Miyazawa, Katsuhito |
Format: | Online-Aufsatz
|
Sprache: | Japanese |
Veröffentlicht: |
2017
|
Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
Schlagworte: | Journal Article
Castration resistant prostate cancer
Docetaxel
Antineoplastic Agents
Taxoids
15H5577CQD |